Trial Profile
A Registry to Assess the Ongoing Safety for Subjects That Have Been Randomized and Completed a Juventas Sponsored Heart Failure Protocol Under IND # 14203
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Jan 2017
Price :
$35
*
At a glance
- Drugs JVS 100 (Primary)
- Indications Heart failure
- Focus Adverse reactions
- Sponsors Juventas Therapeutics
- 22 Apr 2014 New trial record